1. Home
  2. MNY vs RVPH Comparison

MNY vs RVPH Comparison

Compare MNY & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNY
  • RVPH
  • Stock Information
  • Founded
  • MNY 2014
  • RVPH 2006
  • Country
  • MNY Singapore
  • RVPH United States
  • Employees
  • MNY N/A
  • RVPH N/A
  • Industry
  • MNY
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • MNY
  • RVPH Health Care
  • Exchange
  • MNY Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • MNY 43.9M
  • RVPH 26.6M
  • IPO Year
  • MNY N/A
  • RVPH N/A
  • Fundamental
  • Price
  • MNY $1.68
  • RVPH $0.46
  • Analyst Decision
  • MNY Strong Buy
  • RVPH Strong Buy
  • Analyst Count
  • MNY 1
  • RVPH 5
  • Target Price
  • MNY $4.00
  • RVPH $9.00
  • AVG Volume (30 Days)
  • MNY 686.9K
  • RVPH 3.2M
  • Earning Date
  • MNY 09-18-2025
  • RVPH 08-13-2025
  • Dividend Yield
  • MNY N/A
  • RVPH N/A
  • EPS Growth
  • MNY N/A
  • RVPH N/A
  • EPS
  • MNY N/A
  • RVPH N/A
  • Revenue
  • MNY $71,649,746.00
  • RVPH N/A
  • Revenue This Year
  • MNY $16.97
  • RVPH N/A
  • Revenue Next Year
  • MNY $19.35
  • RVPH N/A
  • P/E Ratio
  • MNY N/A
  • RVPH N/A
  • Revenue Growth
  • MNY N/A
  • RVPH N/A
  • 52 Week Low
  • MNY $0.55
  • RVPH $0.30
  • 52 Week High
  • MNY $2.15
  • RVPH $4.28
  • Technical
  • Relative Strength Index (RSI)
  • MNY 60.41
  • RVPH 46.82
  • Support Level
  • MNY $1.88
  • RVPH $0.44
  • Resistance Level
  • MNY $2.13
  • RVPH $0.53
  • Average True Range (ATR)
  • MNY 0.29
  • RVPH 0.04
  • MACD
  • MNY 0.02
  • RVPH 0.02
  • Stochastic Oscillator
  • MNY 58.77
  • RVPH 56.07

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services. Geographically it operates in Singapore, Hong Kong, Taiwan, Malaysia and the Philippines.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: